Updated Jul 16, 2026
Forth Marc has filed 1 SEC Form 4 filing across 1 company in the last 90 days.

Forth Marc is listed as a Director of AEON Biopharma, Inc. in SEC filings with the most recent filing date of 2026-06-22. Publicly available biographical information about this individual is limited. The name may appear in filings as 'Forth Marc' and could also be encountered in the reverse order as 'Marc Forth' depending on document formatting. This entry provides a minimal corporate bio based on the SEC context and available corporate records, with no widely published personal biography identified.
| Role | Director |
|---|---|
| Notability | 20/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-22 | AEON | AEON Biopharma, Inc. | A — Grant or award | 222.7K | $0.00 |
Forth Marc is listed as a Director of AEON Biopharma, Inc. in SEC filings with the most recent filing date of 2026-06-22. Publicly available biographical information about this individual is limited. The name may appear in filings as 'Forth Marc' and could also be encountered in the reverse order as 'Marc Forth' depending on document formatting. This entry provides a minimal co…
1 primary Form 4 filings in the last 90 days, covering 1 company.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Forth Marc profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.